Atlas Trials

Immunocore Ltd

15 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Immunocore Ltd

RecordFirmDate
Study of IMC-S118AI in Type 1 Diabetes (NCT07493122)Immunocore Ltd2026-04-01
Study of IMC-P115C in Advanced PRAME-Positive Cancers (NCT07156136)Immunocore Ltd2024-11-07
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) (NCT06112314)Immunocore Ltd2024-06-05
Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers (NCT06840119)Immunocore Ltd2024-01-10
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) (NCT05549297)Immunocore Ltd2022-12-19
Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection (NCT05867056)Immunocore Ltd2020-08-12
Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors (NCT04262466)Immunocore Ltd2020-02-25
Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab (NCT03973333)Immunocore Ltd2019-05-17
Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers (NCT03515551)Immunocore Ltd2018-06-15
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma (NCT03070392)Immunocore Ltd2017-10-16

Track Immunocore Ltd automatically

Every clearance here is in the API, with alerts when new ones post.